Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients With HIV/HCV Coinfection: Results of an Italian Compassionate Use Program

Patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are at high risk of liver disease progression. We report a favorable safety profile and SVR12 rates of 96.7% among HIV/HCV coinfected patients participating in an Italian compassionate-use program of ombitasvir/p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2017-03, Vol.64 (5), p.680-683
Hauptverfasser:	Andreoni, Massimo, Teti, Elisabetta, Antinori, Andrea, Milazzoi, Laura, Sollima, Savatore, Rizzardini, Giuliano, Di Biagio, Antonio, Saracino, Annalisa, Bruno, Raffaele, Borghi, Vanni, De Luca, Andrea, Cattelan, Annamaria, Hasson, Hamid, Taliani, Gloria, Monforte, Antonella D'Arminio, Mastroianni, Claudio Maria, Di Perri, Giovanni, Bigoni, Sara, Puoti, Massimo, Spinetti, Angiola, Gori, Andrea, Boffa, Nicola, Cacopardo, Bruno, Giacometti, Andrea, Parruti, Giustino, Vullo, Vincenzo, Chirianni, Antonio, Pennica, Alfredo, Pasquazzi, Caterina, Segala, Daniela, Sarmati, Loredana
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral drugs BRIEF REPORTS Hepatitis Hepatitis C virus HIV Human immunodeficiency virus Lentivirus Liver diseases Retroviridae Risk assessment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are at high risk of liver disease progression. We report a favorable safety profile and SVR12 rates of 96.7% among HIV/HCV coinfected patients participating in an Italian compassionate-use program of ombitasvir/paritaprevir/ritonavir + dasabuvir (OBV/PTV/r + DSV) ± ribavirin (RBV).
ISSN:	1058-4838 1537-6591
DOI:	10.1093/cid/ciw846